JO
MHUA

John Overdeck’s Meihua International Medical Technologies MHUA Stock Holding History

John Overdeck’s Portfolio MHUA Stock Details MHUA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-278
Closed -$9.34K – 3391
2025
Q1 		$9.34K Sell
278
-26
-9% -$857 ﹤0.01% 3133
2024
Q4 		$10.5K Buy
+304
New +$18.6K ﹤0.01% 3133

Other funds holding MHUA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

John Overdeck's MHUA Position: Q2 2025 in Review

John Overdeck sold out of Meihua International Medical Technologies (MHUA) in Q2 2025, closing a stake of 278 shares — an estimated $9.34K sold.

John Overdeck first reported a position in MHUA in Q4 2024 and held it in 2 quarters. The position peaked at $10.5K in Q4 2024. 5 funds tracked by Wall St. Rank hold MHUA as of Q2 2025.

  • John Overdeck reported no remaining Meihua International Medical Technologies position as of Q2 2025 after selling out during the quarter.
  • John Overdeck sold 278 Meihua International Medical Technologies shares in Q2 2025, an estimated $9.34K.
  • John Overdeck first reported a position in Meihua International Medical Technologies in Q4 2024 and held it in 2 quarters.
  • John Overdeck's Meihua International Medical Technologies position peaked at $10.5K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Meihua International Medical Technologies as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.